Dr. Rubin on the Second Annual Sherman Prize for Excellence in Crohn’s and Colitis
David T. Rubin, MD, FACG
Recognizing Exceptional and Pioneering Contributions in Crohn’s Disease and Ulcerative Colitis
New Deadline: May 15
By David T. Rubin, MD, FACG, ACG Board of Trustees, Chair, Sherman Prize Selection Committee, University ...
“Enter the Biosimilars”: An ACG-CCFA Webinar with Dr. David T. Rubin
ACG and CCFA Co-Hosted an IBD Circle Webinar
Optimizing Medical Therapy in IBD:
Enter the Biosimilars
June 29, 2016
David T. Rubin, MD, FACG
You can listen this webinar with David T. Rubin, MD, FACG who shares insights on how clinicians ...
Safety and Efficacy of Endoscopic Dilation for Primary Crohn’s Disease Strictures in the Upper GI Tract
Amandeep Singh, MD
Poster 1051 Safety and Efficacy of Endoscopic Dilation for Primary Crohn’s Disease Strictures in the Upper GI Tract
Author Insight from Amandeep Singh, MD, Cleveland Clinic Foundation
What’s new here ...
Oral 26 Visceral Transplantation for End Stage Crohn’s Disease: 25 Years of Experience at a Single Center
*EMBARGOED All research presented at the ACG Annual Scientific Meeting is strictly embargoed until Monday, October 19, 2015 at 8 AM (EDT).
Oral 26 Visceral Transplantation for End Stage Crohn’s Disease: 25 Years of Experience at a Single ...
AJG Co-Editor-in-Chief Paul Moayyedi, MD, FACG, on Noteworthy Biomarker Advances in Gastroenterology Unveiled in June Issue
Paul Moayyedi, MD, FACG
Biomarker advances in gastroenterology are highlighted in a special June issue of The American Journal of Gastroenterology, which also provides new data on how these advances can help the clinician in a wide variety of ...
What an “IBD-ologist” Learned at DDW
Stephen B. Hanauer, MD, FACG
I remain an IBD-ologist and at DDW I tend to focus on advances in our field. So, what did I learn?
IBD causation is not simple or easy (yet). There is a spectrum of complexity between gene and environmental interactions. ...